These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bisphosphonate Combination Therapy in the Management of Postchemotherapy Avascular Necrosis of the Femoral Head in Adolescents and Young Adults: A Retrospective Study From India. Agarwala S; Banavali SD; Vijayvargiya M J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241233 [TBL] [Abstract][Full Text] [Related]
3. Possible beneficial effect of bisphosphonates in osteonecrosis of the knee. Kraenzlin ME; Graf C; Meier C; Kraenzlin C; Friedrich NF Knee Surg Sports Traumatol Arthrosc; 2010 Dec; 18(12):1638-44. PubMed ID: 20376625 [TBL] [Abstract][Full Text] [Related]
4. A Paradigm Shift in Osteonecrosis Treatment with Bisphosphonates: A 20-Year Study. D Orth SA; Vijayvargiya M JB JS Open Access; 2021; 6(4):. PubMed ID: 34934885 [TBL] [Abstract][Full Text] [Related]
5. Does alendronate prevent collapse in osteonecrosis of the femoral head? Nishii T; Sugano N; Miki H; Hashimoto J; Yoshikawa H Clin Orthop Relat Res; 2006 Feb; 443():273-9. PubMed ID: 16462451 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for Post-COVID Osteonecrosis of the Femoral Head: Medical Management of a Surgical Condition. Agarwala S; Vijayvargiya M; Sawant T; Kulkarni S JB JS Open Access; 2022; 7(4):. PubMed ID: 36420354 [TBL] [Abstract][Full Text] [Related]
7. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. Lai KA; Shen WJ; Yang CY; Shao CJ; Hsu JT; Lin RM J Bone Joint Surg Am; 2005 Oct; 87(10):2155-9. PubMed ID: 16203877 [TBL] [Abstract][Full Text] [Related]
8. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Agarwala S; Jain D; Joshi VR; Sule A Rheumatology (Oxford); 2005 Mar; 44(3):352-9. PubMed ID: 15572396 [TBL] [Abstract][Full Text] [Related]
10. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. Agarwala S; Shah S; Joshi VR J Bone Joint Surg Br; 2009 Aug; 91(8):1013-8. PubMed ID: 19651826 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate. Arai R; Takahashi D; Inoue M; Irie T; Asano T; Konno T; Terkawi MA; Onodera T; Kondo E; Iwasaki N BMC Musculoskelet Disord; 2017 Jan; 18(1):24. PubMed ID: 28103867 [TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. Sánchez A; Blanco R Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217 [TBL] [Abstract][Full Text] [Related]
13. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report. Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651 [TBL] [Abstract][Full Text] [Related]
14. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease. Johannesen J; Briody J; McQuade M; Little DG; Cowell CT; Munns CF Bone; 2009 Nov; 45(5):898-902. PubMed ID: 19446052 [TBL] [Abstract][Full Text] [Related]
15. Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review. Luo RB; Lin T; Zhong HM; Yan SG; Wang JA Med Sci Monit; 2014 Nov; 20():2439-47. PubMed ID: 25424061 [TBL] [Abstract][Full Text] [Related]
16. Rationale for prostaglandin I2 in bone marrow oedema--from theory to application. Jäger M; Tillmann FP; Thornhill TS; Mahmoudi M; Blondin D; Hetzel GR; Zilkens C; Krauspe R Arthritis Res Ther; 2008; 10(5):R120. PubMed ID: 18834533 [TBL] [Abstract][Full Text] [Related]
17. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. Fugazzotto PA; Lightfoot WS; Jaffin R; Kumar A J Periodontol; 2007 Sep; 78(9):1664-9. PubMed ID: 17760533 [TBL] [Abstract][Full Text] [Related]
18. Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs. Cheng TL; Murphy CM; Cantrill LC; Mikulec K; Carpenter C; Schindeler A; Little DG Int Orthop; 2014 Jul; 38(7):1527-33. PubMed ID: 24389948 [TBL] [Abstract][Full Text] [Related]
19. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL). Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847 [TBL] [Abstract][Full Text] [Related]
20. Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic. Craig SJ; Youssef PP; Vaile JH; Sullivan L; Bleasel JF Intern Med J; 2011 Feb; 41(2):186-90. PubMed ID: 20214696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]